Research & Development
Academic Report
【Conference presentation】Plasma Aβ assay measured using a fully automated immunoassay platform predicts the amyloid PET status
| Presented by: | Kazuto Yamashita1), Masahiro Miura1), Shunsuke Watanabe1), Kengo Ishiki1), Yuji Arimatsu1), Junko Kawahira1), Toshiko Kubo2), Katsutaka Sasaki1), Takayuki Arai1), Kei Hagino1), Yasuhiro Irino1), Kota Nagai3), David Verbel4), Akihiko Koyama4), Shobha Dhadda4), Hayato Niiro1), Shigeki Iwanaga1), Toshiyuki Sato1), Tomokazu Yoshida1), Atsushi Iwata5) 1) Sysmex Corporation 2) Sysmex R&D Center Americas, Inc. 3) Eisai Co., Ltd. 4) Eisai Inc. 5) Tokyo Metropolitan Geriatric Hospital and Institute of gerontology |
| Academic conference: | The 41st Congress of Japan Society for Dementia Research jointly hosted with the 37th Congress of Japanese Psychogeriatric Society |
| Presentation Date: | November 26, 2022 |
| Overview of presentation: |
Link |
| Notes: | Joint announcement with Sysmex Corporation, Eisai Co., Ltd., and Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology. |
- Information contained in the academic report is current as of the date of the announcement,
but may be subject to change without prior notice.